- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
145 Cards in this Set
- Front
- Back
|
HEART FAILURE: definition & clinical manifestations
congestive symptoms = advanced heart failure |
clinical SYNDROME resulting from any structural or functional cardiac disorder
- problem with heart FILLING WITH (diastolic) or EJECTING (systolic) blood. CARDINAL MANIFESTATIONS: - Dyspnea & fatigue = exercise intolerance (^ LVEDP) - Fluid retention = edema (^ SNS & RAAS) - Multiple organ dysfunction |
|
SYSTOLIC vs DIASTOLIC DYSFUNCTION
sys: vent. dilatation dias: vent. hypertrophy |
SYSTOLIC: heart can't PUMP
- less contraction = less ejection fraction & SV ^ LVEDV & LVEDP --> congestion *common in myocardial ischemia, esp 2' to CAD* DIASTOLIC: heart can't FILL/relax - limited VR (same EF & SV) ^ LVEDP (but not LVEDV) --> same congestive symptoms as systolic fail *1st sign of HYPERTENSIVE heart disease* |
|
DETERMINANTS OF CARDIAC OUTPUT
(myocardial performance) |
CO = HR X SV
SV <-- Preload, afterload, & contractility |
|
PRELOAD
- 2 most important factors - Frank-Starling curve |
preload = SUM of all factors contributing 2 end-diastolic wall tension
1. Sarcomere length 2. LVEDV (3. Amount of VR - total blood volume) *Frank-Starling Curve: LV SV vs. LVEDV & LVEDP* - movement along a SINGLE curvilinear line *As LVEDV Rises, SV will level off, but LVEDP will continue to RISE --> Congestion |
|
Frank-Starling Curve Mechanism
(why does SV change with sarcomere length changes?) |
^ Preload = Increase in sarcomere length...
1. Increased passive elastic forces built-up by TITIN (springy myofibrillar protein) *elastic recoil = main mech 2. Increases sensitivity of contractile proteins to available Ca2+ |
|
SYSTEMIC VENOUS RETURN CURVES
|
CO vs VR (right atrial P)
ex// Increased VR 2' venoconstriction, supine, or ^ reabs = ^ preload = ^ CO |
|
Factors of Preload
(which is a factor of SV) |
1. Sarcomere length
2. LVEDV 3. Total blood volume (VR, posture, neurogenic tone, atrial contraction 4. Contractility |
|
Best clinical measures of preload (RV / LV)
- when would it be false or misleading? |
RV PRELOAD = JVP
LV PRELOAD = PAWP - obstructed artery will feel pressure from pulmonary capillaries <-- pulmonary venous P <---LA Pressure <-- LV EDP *MITRAL STENOSIS: LA-EDP >> LV-EDP *PAWP is also falsely elevated in diastolic dysfxn* (normal LV EDV) |
|
CONTRACTILITY
- how to measure contractility - changes in Vent performance curves & VR curves |
Inherent capacity of mm; Indepent of preload or afterload changes
INCREASED contractility = MORE force generated in SHORTER amount of time. * ^ CO, ^ VR, Decreased RA-P *Shifts Vent Performance Curve (F-S) UP and to the LEFT * Moves up/down SAME VR curve EJECTION FRACTION (SV/EDV) - used to measure contractile state - normal: (50-66%) *BUT, EF is not always right* ( lower EF doesn't always mean decreased contractility) |
|
FACTORS AFFECTED CONTRACTILITY
|
1. Rate of cross-bridge activation and AMOUNT OF CALCIUM available to contractile proteins (Trop C)
- major factor = calcium 2. Circulating Catecholamines 3. SNS activation 4. Acid-base status 5. O2 availability blah blah etc etc #1 only important thing |
|
AFTERLOAD
- main factor - effect on vent performance curve vs. VR |
Sum of loads that contribute to myocardial systolic wall tension
- main factors is TPR VENT. PERFORMANCE CURVE: - Moves up/down only (not L/R like contractiliy) VENOUS RETURN: - Decrease/Increase; different VRs - but SAME mean systemic pressure (x-intercept) * ^ AF (^ TPR) = Dec. CO & SV |
|
BEDSIDE MEASURE OF LV AFTERLOAD
- When do you underestimate AF? (What do you use then?) |
PEAK SYSTOLIC BLOOD PRESSURE
UNDERESTIMATE AF IN AORTIC OUTFLOW OBSTRUCTION (valvular or subvalvular aoric stenosis) - Use peak systolic LV pressure |
|
LAW OF LAPLACE IN AFTERLOAD
|
Amount of systolic wall tension depends on size of ventricular chamber
--> AF decreases throughout ventricular ejection even though systolic BP remains constant TN = (P inside cavity x chamber radius) / (2 x wall thickness) ^ AF with ^ chamber radius & Decreased wall thickness (Vent Dilatation = biggest AF ^ ) ***When contractility is impaired (sys dysfxn), even a SMALL increase in AF decreases SV a LOT*** T = (P x r) / (2 x h) |
|
HEART RATE & MYOCARDIAL FXN
|
(CO = HR x SV)
Tachy: Main mechanism 2 increase CO in exercise >170 is bad: Less diastolic filling = Decreased CO Force-Freq Relation: Tachy = + Inotropic - Treppe phenom: ^ cytoplasmic Ca2+ Systolic Dysfxn: REVERSED force-freq - Tachy decreases contractility (Impaired ca2+ exchange in SR) = Reverse Treppe |
|
CAUSES OF HEART FAILURE:
(8) |
FAILURE DUE TO...
1. Decreased # of myocardial cells (MI, amyloidosis, fibrosis) 2. Decreased intrinsic contractility - sys dysfxn; hypothyroid 3. Excessive External workload - ^ AF (HTN) 4. Valvular abnormality (stenosis/regurg) 5. Cardiac Dysrhythmia (tachy) 6. Congenital malfomration 7. Decreased Vent. Filling ( tamponade, dias dysfxn) 8. Increased metabolic demand ( hyperthyroid, chronic anemia) |
|
MECHANISM OF DECREASED CONTRACTILITY IN SYSTOLIC DYSFXN
|
Irregular Ca2+ cycling
*Phosphates are stuck on proteins = 1. Abnormal Ca2+ cycling by SR (Phospholamban) 2. Abnormal excitation-contraction coupling that links plasma membrane depolarization 2 SR release of Ca2+ 3. ^ Cytoplasmic Ca2+ uncouples oxidative phos = less ATP synthesis 4. Less Myosin ATPase activity (up-reg of beta-myosin heavy chain) 5. Dec activity of phosphocreatine shuttle = less cytoplasmic ATP 6. Less b1-R density/fxn 7. Altered membrane ion channels |
|
SNS Hyperactivity (and PNS hypoactivity) in Heart Failure
*SNS hyperactivity = first finding of Heart failure - sys or dias |
DIRECT EFFECTS OF ^ SNS:
1. Less <3 B1-Rs (protective) - but B2-R INCREASES 2. ^ Serum Catecholamines - Depleted NE stores in neurons to <3 - Adrenal gland synth ^^ bc a2-auto-R are desensitized (^ GRK2) 3. Increases contractility& HR (B1-R) 4. Vasoconstriction (a1-R) 5. Redistributes blood flow from skin/kidneys/splanchnics to CNS & <3 |
|
PROS AND CONS OF SNS HYPERACTIVITY IN SYS DYSFXN
|
ACUTE INCREASED CO = GOOD
- Increases contractility& HR (B1-R) - Vasoconstriction (a1-R) CHRONIC SNS HYPERACTIVE = BAD: - Cardiac remodeling --> dec. <3 fxn - Pulm Edema = ^ LV-AF & ^ LV-Preload (Increased TPR & VR) * Increased Preload = HUGE increase in LVEDP bc noncompliant* - Excess Catecholamines = cytotoxic (b-R) & vent. tachyarrhythmias |
|
SNS HYPERACTIVITY IN DIASTOLIC DYSFXN
|
Serum catecholamine levels are identical to that of Systolic dysfxn
Diff Consequences: - ^ Preload (venoconstrict): More normal increase in SV - ^ AF (^ TPR): Smaller decrease in SV *overall, less negative effect of hyperactivity in diastolic dysfunction* |
|
COMPENSATORY CARDIAC ADAPTATIONS IN SYSTOLIC DYSFXN
*tries to fight low CO* |
1. Sinus tachycardia: 1st bedside symptom
= ^ LV-EDP - SNS hyperactive (still high b2-R density) - ^ CO , but at high E cost - Reverse Treppe phenom - Eventually dec. CO (dec LV-EDV) 2. Ventricular Dilatation - Dev when EF decreases - Increased preload & SV - Reach elastic limit --> Pulmonary congestion - ^ AF (increased raidus & dec. wall thickness); may offset ^ preload benefits - Reduced contractile fxn (slippage of myofibrils) 3. Eccentric Ventricular hypertrophy - Increased preload --> ecc growth - Adds sarcomeres in SERIES --> Cardiomyopathy of overload --> Diastolic dysfunction eventually (dilatation & ecc. hypertrophy) |
|
ECCENTRIC VENTRICULAR HYPERTROPHY
- Mechanism/stimulus/etc *adaptation of systolic dysfunction* ^ Diastolic wall tension --> ecc. hypertrophy |
Normal heart cells: terminally diff'd (G0)
- growing cells can't contract right - Constitutive growth: no increase in cell number/size; replace proteins Dilatation --> Add sarcomeres in series FIRST = GOOD - Decreased AF & ^ LV compliance - ^ CO & SV LATER = BAD - Decreased contractility ( weird Ca2+ cycling & increased E cost) - ATP depletion --> ischemia & necrosis - Same stimuli to grow now accelerates apoptosis - Increased fibrosis - Surviving cells hypertrophy --> repeat cycle of death & hypertrophy = Cardiomyopathy of overload (ventricular remodeling) |
|
DEVELOPMENT OF DIASTOLIC DYSFUNCTION IN SYSTOLIC DYSFXN
|
PROBLEM RELAXING IN HYPERTROPHIED CELLS
- Less SERCA activity (ATP-dep) - Weird Phospholamban (reversible inhibitor of SERCA) *Concentric hypertrophy can develop in pressure overloaded situations --> also can lead to CM of overload |
|
DRUGS TO TREAT SYSTOLIC FAILURE
|
Beta blockers & ACE INHIBITORS
- retard cell loss from apoptosis & necrosis - Inhibits maladpative growth - Lowers energy expenditure *both drugs IMPROVE LONG TERM SURVIVAL in SYSTOLIC failure* (not sure about diastolic) |
|
DEVELOPMENT OF DIASTOLIC DYSFUNCTION IN SYSTOLIC DYSFXN
|
PROBLEM RELAXING IN HYPERTROPHIED CELLS
- Less SERCA activity (ATP-dep) - Weird Phospholamban (reversible inhibitor of SERCA) *Concentric hypertrophy can develop in pressure overloaded situations --> also can lead to CM of overload |
|
DRUGS TO TREAT SYSTOLIC FAILURE
|
Beta blockers & ACE INHIBITORS
- retard cell loss from apoptosis & necrosis - Inhibits maladpative growth - Lowers energy expenditure *both drugs IMPROVE LONG TERM SURVIVAL in SYSTOLIC failure* (not sure about diastolic) |
|
Starling Equation
|
Qf = K [(HPc - HPis) - o (OPc - OPis)]
+Qf = leaving capillary |
|
Development of pulmonary edema in <3 failure
--> CONGESTIVE HEART FAILURE - PAWP leading to edema |
Normally, lymphatic circulation increases to remove excess fluid, this is not enough at
acute: >25 mmHg chronic: >28-30 mmHg Interstitial edema --> alveolar edema *If liver dysfxn also, serum albumin will be low & edema can develop MUCH more quickly* |
|
Plain Chest X-ray findings of early & late pulmonary edema:
*hypoxic vasoconstriction of lower lobe vessels --> cephalization of vasculature |
- Cardiomegaly
- Prominent Upper lobe vessels (Cephalization) - Alveolar edema in lung bases - Pleural effusions - Kerley B lines |
|
PULMONARY MANIFESTATIONS OF LV FAILURE
|
1. Dysnpea: most common
- Increased work of moving non-compliant (edematous) lungs - vagal afferents from J receptors, small airway receptors, epithelial irritant receptors --> tachypnea --> Increased work 2. Dyspnea on Exertion (DOE) - ACUTE: heart failure - Gradual onset: chronic lung dz 3. Orthopnea (dyspnea on recumbency) - ^ VR = ^ LVEDP = ^ HPc 4. PND - mechanisms similar to orthopnea + dulling of the respiratory center to stimuli - Edema fluid from legs & lungs take a while to re-enter circulation 5. BL late-inspiratory crackles/rales - first in lung bases --> apex 6. Hemoptysis - resp fail, alv. edema, pulm HTN |
|
CV Manifestions of LV FAILURE
- mitral regurg can occur 2' vent. dilatataion (murmur) - weakness, fatigue, lassitude, etc = decreased CO |
1. Catecholamine effects:
- cold/clammy skin - Heat intolerance 2. Sinus Tachycardia - Pulsus alternans can occur (EF < 20%) *RESTING HR IS HIGHEST SPECIFICITY 2 DX <3 FAIL* 3. Abnormal CV response to Valsalva. High spec/sen - less severe dz: no phase 4 (absent overshoot) - more severe dz: Square wave (maintained LVEDP during strain despite super drop in VR) 4. Apical impulse: - Sustained (concentric LVH) - Displaced (dilatation) 5. S3 |
|
MANIFESTATIONS OF RV FAIL
(cor pulmonale) |
1. Left sided parasternal impulse
2. S3 3. Tricuspid regurg (2' dilatation) 4. Elevated systemic venous pressure ---> ^ JVP, Hepatojugular reflux, hepatomegaly & ascities, peripheral dependent edema (pretibial vs presacral) |
|
RAAS ACTIVATION IN SYSTOLIC DYSFUNCTION
- RAAS PATHWAY - ANGII EFFECTS *Protects kidney, but damages heart* |
1. Increased SNS activity
- kidney, b1-R 2. Reduced renal blood flow - JG apparaturs (baroreceptors) --> RENIN RELEASE --> ^ ANG I (ACE) --> ANG II --> Aldosterone ANG II: - potent vasoconstrictor (AT1-R) - Increased Na+/H2O reabs in proximal tubule - Enhances <3 contracility & hypertrophy --> myocardial ischemia, necrosis, apoptosis |
|
RAAS
- ENZYMES - SOURCES OF ALDOSTERONE * tissue ACE & tissue chymase are UPREG'd in heart failure = ^^^ ANGII |
Plasma ACE: GOOD
- 10% total ACE - mostly beneficial: Maintains BP & renal perfusion TISSUE ACE: BAD - 90% ACE - mostly bad: causes inflamm, hypertrophy, and fibrosis Chymase (interstitial cells): BAD - mainly in myocardium - stimulates growth ANGII stimulates aldosterone synthesis in adrenal glands & vascular endothelial cells & vasc SM cells |
|
ANG II EFFECTS AT THE KIDNEY, HEART, VASCULATURE
|
Increased GFR
- Vasoconstrict afferent arteriole via ca2+ influx (Ca2+ blockers & ACE-I) - Vasoconstrict efferent arteriole by using internal stores of Ca2+ (ACE-Is only) **Can constrict Efferent more to ^ GFR ( >%age of RBF) Increased Na+/H2O retention = ^ OPc - stimulates luminal Na+/H+ exchanger in prox tubule *Potent Vasoconstrictor (AT1-R) - increased AF (maintains BP, but decreases CO even more) HEART: - Increases contractility via cAMP (b1, b2) & IP3 (AT, alpha, ETa) - Induces proto-oncogenes --> Hypertrophy --> ischemia, necrosis, apoptosis |
|
ALDOSTERONE EFFECTS
|
HEART:
- Hypertrophy, remodel, & fibrosis --> CM of overload (^ cell loww) - Decreased NO = Decreased coronary blood flow = Myocardial ischemia & worse SYSTOLIC DYSFXN VASCULATURE: ^ BP - ^ SNS outflow fro CNS = ^ afterload - Na+ reabs in distal nephron = ^ preload |
|
ADH IN HEART FAILURE
(ARGININE VASOPRESSIN) - STIMULI FOR RELEASE - mech of axn **you get serum hyponatremia, even though total body sodium content is increased** |
1. SNS activation: MAIN reason for increased ADH
- decreased CO stimulates SNS activation - ATN II activation overrides the osmotic control mechanisms of ADH release 2. Serum Hypertonicity 3. Hypovolemia 4. ATN III (cleavage product of ATN II) A. V2-R to increase H2O reabs in medullary collecting ducts (^ preload) = hyponatremia (bad prognosis in <3 fail) B. V1-R: vasoconstrict (^ afterload) C. V1a --> LV hypertrophy/remodeling |
|
ADH DRUGS
|
1. V1 & V2-R antags (conivaptan)
- increase free H2O excretion and increase serum Na+ concentration 2. V2 antags (tolvaptan) *vaptans = aqua-retics |
|
NATRIURETIC PEPTIDES
- what - where - levels in heart failure |
Stimulus for release: distention
ANP = R Atrium BNP = Ventricles CNP = Vasculature * Neutral endopeptidase clear the NPs. *ALL LEVELS ARE HIGHER IN HEART FAILURE* - ATRIA MAKES WAY MORE BNP & CNP |
|
NATRIURETIC PEPTIDES
AXNS GOOD! (but not enough to fight RAAS) |
1. balanced vasodilatation (^ cGMP & less intracell Ca2+)
= less preload & AF 2 .Redistributes plasma volumes into extravascular space = Reduced Preload 3. NATRIURESIS & DIURESIS ^ GFR : Dilates aff & constricts eff, relaxes mesangial cells - Inhibits renin release & aldosterone secretion - Antagonizes vasopressin & ATN ii effcts in kidneys 4. Decreases Cardiac remodeling & decreases myocardial apoptosis *effects diminish as CHF worsens; receptors are down-reg'd and so much Na+ gets reabs'd early on, not much is excreted in distal nephron* |
|
SERUM BNP & HEART FAILURE
|
in CHF, atria makes all three types of natriuretic peptides
- Serum BNP correlates with EDP & LV wall TN - does NOT differentiate b/w Sys vs. Dias dysfxn - Serium BNP > 100pg/mL has HIGH sens & spec in differentiating dyspnea cuased by <3 failure vs. others causes (lung dz) |
|
WHAT HAPPENS TO THE LIVER IN HEART FAILURE?
|
1. Liver edema <-- systemic venous congestion (R<3 fail)
- around central liver venules (fibrosis) - hepatic arteriole areas are spared 2. Hepatocellular Damage - increased ALT/AST levels - alkaline phosphatase & bili can also increase 2' intrahepatic cholestasis 3. Cardiac cirrhosis = nutmeg liver 4. Decreased plasma colloid oncotic pressure - edema is worsened everywhere 5. Ascites <-- increased hepatic sinusoidal pressure |
|
Cytokine storm of heart failure
- what cytokines? - effects? |
1. TNFa = pro-inflamm
- increased in systolic dysfxn - released by <3 & vasculature - Cachexia (anorexia, muscle waste, no appetite) - Slippage of sarcomeres (dilatation) - ^ myocardial proteins ( hypertrophy) - Cell loss <--- apoptosis - decreases contractiliy (NO) 2. NO - increased cGMP in heart - negative inotropic effects (inhibits Ca channels) 3. Endothelin-1 - heart also makes this in <3 fail - ^ preload & AF & stimulate's hypertrophy - does a LOT of stuff; mostly bad - initially decreased contractility - vent remodeling etc etc etc |
|
APOPTOSIS IN HEART FAILURE
|
NORMAL: 1-2% cells
HEART FAIL: up to 40% ATP-DEPENDENT process - cell membrane remains intact INDUCERS OF APOPTOSIS: - NO, Free radicals, TNFa, ATN II,ET-1, Catechoalmines, Ca2+ overload *Hypertrophy tries to compensate, but ultimately makes things worse |
|
Pharmacotherapy in heart failure
**CAD and Kidney failure are the #1 cardiac & non-cardiac causes of heart failure |
Volume of distribution DECREASES in proportion to severity of heart failure
- need to decrease loading dose of meds - also need to factor in any renal & hepatic dysfxn |
|
CARDIOMYOPATHY
- DEFINE |
Diseases of the myocardium associated w/ mechanical/electrical dysfunction
- usually with inappropriate ventricular hypertrophy or dilatation - can be primary or secondary *first indication of CM in many pts is SUDDEN DEATH* |
|
CARDIOMYOPATHY
- TYPES OF FUNCTIONAL IMPAIRMENT |
1. Dilated (congestive) CM
- systolic dysfxn & vent dilatation 2. Hypertrophic CM - Diastolic dysfxn& vent. hypertrophy - conduction disturbances & suddent death - young adults 3. RESTRICTIVE CM: uncommon - restricted filling of the ventricle & infiltration/obliteration of myocardium w/ NON-cardiac junk 4. Arrhythmogenic RV CM: uncommon - RV myocardial electrical instability - loss of myocytes with fibrofatty tissue replacement |
|
PRIMARY HYPERTROPHIC CARDIOMYOPATHY (HCM)
etiology & morphology MOST COMMON!! (auto dom) |
Most common primary CM
- most common cause of SUDDEN CARDIAC DEATH in young adults & athletes Most common: Mutations in b-myosin heavy chain gene & Myosin-binding protein C gene MORPHOLOGY: - Concentric hypertrophy - Asymmetric hypertrophy involves the IV septum more --> LV outflow obstruction - Uncontrolled parallel, disorganized hypertrophy = WAVY FIBERS; SWIRLY, perpendicular *Fibrosis - if septal hypertrophy & fibrosis --> AV conduction disturbances (bundle block) *Intramural coronary aa messed up --> myocardial ischemia |
|
PRIMARY HCM
PATHOPHYS - normal: LA contraction = 10% vent. filling **A-FIB IS SO BAD** - FORWARD CO is pretty well preserved unless IHSS is really bad |
Normal EJECTION FRACTION
-Concentric LVH = less afterload = ^ SV - Decreased contractility LV OUTFLOW OBSTRUCTION - SAM - can be labile obstruction caused by ^ contractiliy or decreased Preload/af *WATCH OUT FOR DIURETICS & VASODILATORS* Diastolic Dysfxn: - Hypertrophy & fibrosis = rigid passive relaxation - Less Ca2+ reuptake = bad active relaxation - LA contraction = SUPER NECESSARY (60% vent. filling) SNS increases - sinus tachy worsens CO - Increased contractiliy worsens LV outflow obstruction & worsens CO |
|
SAM IN HOCM
|
LV OUTFLOW OBSTRUCTION
- SAM: Systolic anterior motion of mitral valve contacts IV septum - Chordal elongation & ant. displacement of papillary mm = SUBAORTIC STENOSIS (not the norm) |
|
DOC for PRIMARY HCM
|
BETA-BLOCKERS
- relieve symptoms: 1. decrease HR (improve vent. fillin) 2. Decrease contractility (lessen LV outflow obstruction) 3. Decrease myocardial O2 consumption (less ischemia) 4. Helps prevent a-fib |
|
SIGNS AND SYMPTOMS OF PRIMARY HCM
*valsalva makes the <3 smaller* |
^PAWP
- Dyspnea on exertion Exertional angina - abnormally small intramural coronary aa can't provide enough blood to hypertrophied heart Fatigue & Syncope - low forward CO (in cases of IHSS) Vent. tachy & fibrillation = most common causes of sudden death - diastolic heart failure can also be a problem (gradual issue) Bifid carotid pulse if obstruction present - S4 in sinus rhythm - Systolic murmur w/ outflow prob *murmur increases w/ sustained valsalva & decreases w/ squatting |
|
PRIMARY DILATED/CONGESTIVE CM
1/3 of dilated CM etiology & morphology |
Mainly auto dom
- abnormal cytoskeletal proteins & sarcomere proteins that anchor sarcomeres to cell membrane or nucleus VIRAL: Coxsackievirus B & adenovirus - elevated cardiac enzymes (necrosis) MORPHOLOGY: - Vent. dilatation (out of proportion to any hypertrophy going on) - Vacuolated myocardiocytes - big nuclei (polyploid) - fibrous infiltration |
|
secondary causes of dilated CM
|
1. CAD
2. Endocrine: Diabetes, HTN 3. Toxins & Drugs: - Alcohol - Chemo: Doxorubicin, Daunorubicin, Herceptin *generate free radicals* |
|
PATHOPHYSIOLOGY OF DCM (CCM)
*BL VENTRICLE FAILURE IS CHARACTERISTIC OF DCM = simultaneous pulmonary & systemic venous congestion |
Decreased contractiliy is the MAIN PROBLEM
- sarcomere sucks - decreased myocardiocytes bc cytockeletal proteins suck = apoptosis/necrosis - Down-reg's B1-R = DECREASED EJECTION FRACTION (Major diff from HCM) - Increased LVEDV MAIN COMPENSATION: RAAS & SNS - Acute: ^ CO, ^ BP, ^ Contractiliy - bad chronically --> CM of overload (already had it) |
|
TX OF DCM
|
beta-blockers & ACE inhibitors
(carvedilol & enalapril) - retard cell loss & vent. remodeling *may acutely decrease contractiliy also: - arteriovasodilators (decrease preload & AF) - contractility enhancers ( ^ CO) - diuretics (decrease preload) |
|
SIGNS AND SYMPTOMS OF DCM/CCM
*NO EVOLUTION OF SYMPTOMS - R & L <3 symptoms at the same time |
CONSISTENT W/ BIVENTRICULAR FAILURE (simultaneous onset)
- displaced LV & RV impulses - S3 - Late inspiratory crackles - Elevated JVP - hepatomegaly& dep. pitting edema - Mural thrombi (stagnant blood) - Arrhythmias: dilatation & excess SNS *sudden death* - Exercise intolerance: low forward CO - Pumonary stuff (high PAWP) |
|
PROGNOSIS OF DCM
|
50% die of pump failure or sudden death (arrhythmias)
- w/in 5 yrs w/o transplant Long term tx w/ ACE inhibitors & beta blockers (carvedilol) have improved survival * need to add warfarin bc of high embolism risk |
|
RESTRICTIVE CM
Etiology & Morphology RAREST |
Rarest, worst prognosis
- mostly secondary causes = infiltration of cardiac interstitium (amyloidosis) or cells (hemochromatosis) - obliterative diseases also cause this (carcinoid endomyocardial fibrosis) |
|
PATHOPHYSIOLOGY OF RESTRICTIVE CM
- looks like? |
Myocardial restriction to diastolic filling
- reduced LV & RV volumes - Nearly normal systolic fxn - NORMAL EF - decreased SV & CO & LVEDV Looks like constrictive pericarditis - use Plasma BNP to tell the difference - normal BNP in CP ^ LVEDP at onset of diastole - Characteristic fillin pattern: square root / dip & plateau / M pattern - Atrial P is much higher - Filling is mostly down by mid-diastole (plateau) - same filling pattern in CP LV filling pressure > RV filling pressure - also used to distinguish from CP |
|
TX OF RESTRICTIVE CM
|
GIVE THE HEART ENOUGH TIME TO FILL - control tachy
- beta blockers - calcium blockers *use diuretics w/ caution ( decrease SV too much) *a-fibs would be DISASTROUS - atrial contraction is SUPER important to fill the tiny chamber |
|
SIGNS & SYMPTOMS OF RESTRICTIVE CM
|
1. Normal heart size
2. Biventricular failure - simultaneous onset of symptoms like in DCM 3. cHARACTERIS FILLING PATTERN - elevated JVP: large & rapid x & y descents 4.S3 & S4 may be present; apical impulse normal but reduced in amplitude |
|
SECONDARY FORMS OF CARDIAC HYPERTROPHY
- etiology & morphology *all causes are associated w/ myocardial fibrosis* ***LV HYPERTROPHY = MOST POWERFUL PREDICTOR OF ADVERSE CV OUTCOMES iN HTN PTS **** |
1. Concentric hypertrophy
- pressure overload - add sarcs in parallel - Causes: HTN & AS, DM, PULM HTN - 1' vs 2' hypertrophy: In 2' = Orderly, uniform enlargements; no fiber disarry***** 2. Eccentric hypertrophy - volume overload - add sarcs in series - myocardial mass is greater, even tho wall looks thinner - Causes: ischemia & chronic valvular regurg *most common cause of RVH eccentric is LV systolic dysfxn |
|
PATHOPHYSIOLOGY OF 2' Cardiac hypertrophy
- initial effects |
INITIALLY: ADAPTIVE
1. Decrease AF (normalize systolic wall stres) - maintain CO 2. Metabolic switching - Switches from FFA (70% ATP) Powerhouse to a Glucose powerhouse. *except in DM* - More efficient: more ATP/O2 - Affects tsc of FA oxidation& glucose metab genes |
|
PATHOPHYSIOLOGY OF 2' Cardiac hypertrophy
- later effects/ bad effects **FIBROSIS distinguishes bw pathologic & physiologic hypertrophy** |
1.Decreased relaxation: immediate
- increased collagen synthesis & less degradation - Affects contractiliy, relaxation rate, passive filling - ACE inhibis & Aldosterone antags dcrease collagen synth & reverse fibrosis 2. Perivascular fibrosis - limits coronary blood flow & myocardial E production - reduced blood flow relative to increased mass it needs to perfuse 3. Diastolic dysfxn --> systolic dysfxn as muscle mass increases 4. Ventricular arrhythmias more likely - conduction block - facilitates re-entry |
|
DOC for pathologic hypertrophy
(2' hypertrophy) |
ACE-Inhibitors & beta-blockers
- decrease fibrosis & improve <3 fxn New class of drugs: 3-keto acyl CoA thiolase inhibitor - swtiches <3 metabolism from FFA to glucose - not in use yet |
|
PATHOLOGIC HYPERTROPHY
- CHARACTERISTICS - drugs |
MYOCARDIAL FIBROSIS
- distinguishes pathologic vs physiologic - ^ collagen synthesis and decreased degradation - Profibrotic substances: prorenin, ATN II, alodsterone, growth factors, catecholamines, etc *Initially improves CO, but then decreases myocardial relaxation - plasma concentration of PROCOLLAGEN TYPE 1 correlates w/ amt of fibrosis. ( --> type 1 collagen) ACE inhibitors & aldosterone antags - decrease collagen synthesis & partially reverse fibrosis in hypertensive <3 dz |
|
PATHOLOGIC HYPERTROPHY
- CHARACTERISTICS - drugs |
MYOCARDIAL FIBROSIS
- distinguishes pathologic vs physiologic - ^ collagen synthesis and decreased degradation - Profibrotic substances: prorenin, ATN II, alodsterone, growth factors, catecholamines, etc *Initially improves CO, but then decreases myocardial relaxation - plasma concentration of PROCOLLAGEN TYPE 1 correlates w/ amt of fibrosis. ( --> type 1 collagen) ACE inhibitors & aldosterone antags - decrease collagen synthesis & partially reverse fibrosis in hypertensive <3 dz |
|
PATHOLOGIC HYPERTROPHY
- CHARACTERISTICS - drugs |
MYOCARDIAL FIBROSIS
- distinguishes pathologic vs physiologic - ^ collagen synthesis and decreased degradation - Profibrotic substances: prorenin, ATN II, alodsterone, growth factors, catecholamines, etc *Initially improves CO, but then decreases myocardial relaxation - plasma concentration of PROCOLLAGEN TYPE 1 correlates w/ amt of fibrosis. ( --> type 1 collagen) ACE inhibitors & aldosterone antags - decrease collagen synthesis & partially reverse fibrosis in hypertensive <3 dz |
|
PATHOLOGIC HYPERTROPHY
- CHARACTERISTICS - drugs |
MYOCARDIAL FIBROSIS
- distinguishes pathologic vs physiologic - ^ collagen synthesis and decreased degradation - Profibrotic substances: prorenin, ATN II, alodsterone, growth factors, catecholamines, etc *Initially improves CO, but then decreases myocardial relaxation - plasma concentration of PROCOLLAGEN TYPE 1 correlates w/ amt of fibrosis. ( --> type 1 collagen) ACE inhibitors & aldosterone antags - decrease collagen synthesis & partially reverse fibrosis in hypertensive <3 dz |
|
PATHOLOGIC HYPERTROPHY
- progression ---> maladaptive |
PERIVASCULAR FIBROSIS
- limits coronary blood blood & myocardial energy production *normal resting CBF, but reduced RELATIVE to increased <3 mass - Coronary vasodilatory reserve is much reduced in hypertensive pts w/ concentric LVH 1st. Diastolic dysfxn 2nd. Systolic dysfxn *ventricular arrhythmias much more likely* - fibrosis facilitates the development of re-entry (?) |
|
PATHOLOGIC HYPERTROPHY
- progression ---> maladaptive |
PERIVASCULAR FIBROSIS
- limits coronary blood blood & myocardial energy production *normal resting CBF, but reduced RELATIVE to increased <3 mass - Coronary vasodilatory reserve is much reduced in hypertensive pts w/ concentric LVH 1st. Diastolic dysfxn 2nd. Systolic dysfxn *ventricular arrhythmias much more likely* - fibrosis facilitates the development of re-entry (?) |
|
PATHOLOGIC HYPERTROPHY
- progression ---> maladaptive |
PERIVASCULAR FIBROSIS
- limits coronary blood blood & myocardial energy production *normal resting CBF, but reduced RELATIVE to increased <3 mass - Coronary vasodilatory reserve is much reduced in hypertensive pts w/ concentric LVH 1st. Diastolic dysfxn 2nd. Systolic dysfxn *ventricular arrhythmias much more likely* - fibrosis facilitates the development of re-entry (?) |
|
PATHOLOGIC HYPERTROPHY
- progression ---> maladaptive |
PERIVASCULAR FIBROSIS
- limits coronary blood blood & myocardial energy production *normal resting CBF, but reduced RELATIVE to increased <3 mass - Coronary vasodilatory reserve is much reduced in hypertensive pts w/ concentric LVH 1st. Diastolic dysfxn 2nd. Systolic dysfxn *ventricular arrhythmias much more likely* - fibrosis facilitates the development of re-entry (?) |
|
PATHOLOGIC HYPERTROPHY
- CHARACTERISTICS - drugs |
MYOCARDIAL FIBROSIS
- distinguishes pathologic vs physiologic - ^ collagen synthesis and decreased degradation - Profibrotic substances: prorenin, ATN II, alodsterone, growth factors, catecholamines, etc *Initially improves CO, but then decreases myocardial relaxation - plasma concentration of PROCOLLAGEN TYPE 1 correlates w/ amt of fibrosis. ( --> type 1 collagen) ACE inhibitors & aldosterone antags - decrease collagen synthesis & partially reverse fibrosis in hypertensive <3 dz |
|
PATHOLOGIC HYPERTROPHY
- progression ---> maladaptive |
PERIVASCULAR FIBROSIS
- limits coronary blood blood & myocardial energy production *normal resting CBF, but reduced RELATIVE to increased <3 mass - Coronary vasodilatory reserve is much reduced in hypertensive pts w/ concentric LVH 1st. Diastolic dysfxn 2nd. Systolic dysfxn *ventricular arrhythmias much more likely* - fibrosis facilitates the development of re-entry (?) |
|
PATHOLOGIC HYPERTROPHY
- CHARACTERISTICS - drugs |
MYOCARDIAL FIBROSIS
- distinguishes pathologic vs physiologic - ^ collagen synthesis and decreased degradation - Profibrotic substances: prorenin, ATN II, alodsterone, growth factors, catecholamines, etc *Initially improves CO, but then decreases myocardial relaxation - plasma concentration of PROCOLLAGEN TYPE 1 correlates w/ amt of fibrosis. ( --> type 1 collagen) ACE inhibitors & aldosterone antags - decrease collagen synthesis & partially reverse fibrosis in hypertensive <3 dz |
|
PATHOLOGIC HYPERTROPHY
- progression ---> maladaptive |
PERIVASCULAR FIBROSIS
- limits coronary blood blood & myocardial energy production *normal resting CBF, but reduced RELATIVE to increased <3 mass - Coronary vasodilatory reserve is much reduced in hypertensive pts w/ concentric LVH 1st. Diastolic dysfxn 2nd. Systolic dysfxn *ventricular arrhythmias much more likely* - fibrosis facilitates the development of re-entry (?) |
|
Preload changes and PV loops
|
Increase preload:
- shifts curve to the RIGHT (and up a little) - increases diastolic filling & SV DECREASE: - Moves it down and to the left *same F-S curve |
|
AFTERLOAD CHANGES & PV LOOPS
|
INCREASE AFTERLOAD:
- Moves up, and rectangle gets smaller - shortened ventricular ejection = longer isovolemic contraction & decreased SV DECREASED: - Moves down and to the left *shifts up/down a F-S curve* |
|
CONTRACTILITY CHANGES & PV LOOPS
|
INCREASED:
- UP and to the LEFT DECREASED: down & to the right (Systolic Dysfxn looks like this - problem contracting) *different F-S curves, move pts along a slope* |
|
DIASTOLIC DYSFXN
- PV LOOP |
moves UP and to the LEFT
if due to LVH - diastolic filling has an upward slope if due to SERCA problem (reuptake of Ca2+) - downward slope of diastolic filling. |
|
MITRAL STENOSIS
- PATHOPHYS |
20-40 yr after RHEUMATIC FEVER
- progressive narrowing of orifice (valve fusion) = diatolic pressure gradient *Less LV filling = Less forward CO Exercise causes initial symptoms: Tachy: decreases time spent in diastole - reduces SV and Raises LA-P Increased CO: Increases pressure gradient --> LEFT ATRIAL CONCENTRIC HYPERTROPHY --> CHRONIC BUILDUP OF PRESSURE --> PULM HTN --> concentric RVH --> RIGHT HEART FAIL LEFT VENTRICLE IS FINE IN ALL OF THIS!! |
|
MITRAL STENOSIS
- CAUSES - PATHOPHYS - |
20-40 yr after RHEUMATIC FEVER
(valve fusion) diastolic pressure gradient develops from LA to LV - Chronic Elevation of LA-P = concentric LAH --> Pulm vasc hypertrophy/HTN ---> concentric RVH ---> Right heart failure *pulm edema occurs after HPc gets too high* LV IS TOTALLY NORMAL - Contractility is fine - normal afterload? *Decreased SV & CO & EDV |
|
MITRAL STENOSIS
- Symptoms - aggravating factors *IMPORTANT* - Distance bw A2-OS varies inversely w/ level of LA-P *short interval = BAD STENOSIS/HIGH LA-P* |
#1. DOE: tachy & ^ CO requirement
- Increased work of breathing 2' pulmonary congestion 2. Orthopnea 3. PND 4. Hemoptysis (rupture under high HPc) 5. Palpitations (a-fib) 6. Systemic emboli 7. Right heart failure signs: ascites, high JVP, Hepatomg edema) 8. Normal impulse for a long time ----> sustained parasternal impulse 8.CARDIAC TRIAD: Loud S1, opening Snap low-pitched, rumbling diast murmur w/ presystolic accentuation *Anything that produces Tachy & increased CO makes it worse - less time for LV filling - Greater pressure gradient developed bw LA & LV (edema) |
|
MITRAL STENOSIS COMPLICATIONS
|
A-FIB ---> MURAL THROMBI
*a-fib is poorly tolerated* - No atrial contraction = worse LV filling - Increased Pulmonary venous congestion - Systemic & pulmonary thrombi (Ca2+ channels open more readily 2' dilatation?) **no presystolic accentuation if a-fib is present* |
|
RADIOGRAPHIC FINDINGS IN MS
|
4 BUMPS
- Abnormal bump = hypertrophied LA - Esophageal constriction 2' to LAH - No clear space bw RV & sternum 2' RVH |
|
CHRONIC MITRAL REGURG
- cause - PATHOPHYS ^LVEDP --> LV dilatation ---> eccentric hypertrophy (pretty well tolerated, like other chronic regurg's) *Afterload is inversely related to SV & max rate of velocity of ejection* |
USA- MVProlapse
Others - Rheumatic fever SHORT isovolemic contraction & LONG ejection phase - LV afterload = LA-P Decreased AF Increased Contractility Increased Preload - Increased SV GREAT ejection fraction (~80%) Normal-Decreased Forward CO - ^^^ total CO Eccentric LVH 2' LV dilatation ---> LV systolic dysfxn --> backup of pressures (BAD!) |
|
CHRONIC MR
tx? |
VASODILATORS
(AF reducers; decrease TPR) - any increases in AF are dangerous bc they decrease forward CO - more blood --> LA means pulmonary congestion |
|
RADIOGRAPHIC FINDINGS IN MS
|
4 BUMPS
- Abnormal bump = hypertrophied LA - Esophageal constriction 2' to LAH - No clear space bw RV & sternum 2' RVH |
|
CHRONIC MITRAL REGURG
- cause - PATHOPHYS ^LVEDP --> LV dilatation ---> eccentric hypertrophy (pretty well tolerated, like other chronic regurg's) *Afterload is inversely related to SV & max rate of velocity of ejection* |
USA- MVProlapse
Others - Rheumatic fever SHORT isovolemic contraction & LONG ejection phase - LV afterload = LA-P Decreased AF Increased Contractility Increased Preload - Increased SV GREAT ejection fraction (~80%) Normal-Decreased Forward CO - ^^^ total CO Eccentric LVH 2' LV dilatation ---> LV systolic dysfxn --> backup of pressures (BAD!) |
|
CHRONIC MR
tx? |
VASODILATORS
(AF reducers; decrease TPR) - any increases in AF are dangerous bc they decrease forward CO - more blood --> LA means pulmonary congestion |
|
SYMPTOMS OF CHRONIC MR
|
1. Fatigue with exercise
---> Dyspnea on exertion 2. Dyspnea, orthopnea, & PND - ^ PAWP (giant V waves) 3. Palpitations (arrhythmias) 4. Hyperdynamic lateral apical impulse (big SV) 5. Apical holosystolic murmur - radiates into Left axilla - intensity correlates w/ severity - Increased afterload = ^ intensity 6. S3 (does not tell u severity - only in AR) |
|
ACUTE MR
- PATHOPHYS/CAUSE *same diastolic pressure curves (decreased in chronic MR) |
USUALLY ruptured chordae tendineae after MI
- no time for LA dilatation - MARKED increase in LA-P - RAPID pulm edema - forward CO is severely reduced --> systemic hypoperfusion/hypoTN |
|
MITRAL VALVE PROLAPASE
(probably inherited; auto dom) CAUSE/PATHOPHYS |
Myxomatous degen of mitral valve
- more common in women, worse prognosis in men - usually benign *most common cause of MR* PATHOPHYS: Chordae get too long for annulus - decreased LVEDV ---> MVP earlier in LV systole *many pts have ^ SNS activity and high plasma catecholamines |
|
MVP
- FINDINGS Timing: Size of heart Intensity = AF (LV vol) |
1. Midsystolic click
- tensing of elongated chordae - smaller heart move click CLOSER to S1 (standing / sustained Valsalva) - Bigger heart (squat, handgrip) = move click closer to 2nd heart sound 2. Late systolic murmur = mild MR - intensity correlates w/ severity - Decreased LV Vol (increased contractility/decreased preload) prolong duration & increase murmur *decreased AF prolongs murmur, but less intense |
|
MVP
- SYMPTOMS - PROGNOSIS |
most are asymptomatic
- palpitations - brief episodes of sharpk, precordial chest pain - anxiety (high SNS activity) PROGNOSIS: 1. 15% (MOSTLY MEN) WILL HAVE PROGRESSIVE MYXOMATOUS DEGEN OF MV --> severe MR (need replacement) 2. Embolic events (women>men) - TIAs & storkes - birth control pills 3. Infective endocarditis *MVP is the most common predisposing factor |
|
VALVULAR AORTIC STENOSIS
- PATHOPHYS *VERY similar to atherosclerosis* (vasodilators won't help, cuz sys BP isn't in picture) |
Active inflamm process (like CAD) ----> Valvular calcification (or congenital bicuspid aorta)
Risk factors: HTN & hyperlipidemia - correlates w/ ^ CRP ^ AF (systolic wall TN) causes Systolic P Gradient (LVESP = AF) --> LVH Concentric (-->sys dysfxn) ---> LV dilatation (^ preload; then diastolic dysfxn) |
|
bad news bears about AS
- consequences of LVH & DILATATION |
LVH CONCENTRIC
- Increases O2 demand in face of ltd CBF --> Myocardial ischmia --> Systolic dysfxn = Dec EF, Inc LVEDV, LVEDP LV DILATATION - late development - ^ preload to sustain SV - SUCKS bc of diastolic dysfxn (small V increase; HUGE P increase) |
|
SIGNS & SYMPTOMS OF AS
*boot-shaped heart* - no atrial appendage early in dz |
1. TRIAD: angina, exertional dyspnea, & syncopee during exertion
- O2 demand, high PCWP, Decreased CO 2. Systemic Vasodilation (local metabs) - Decreased VR --> syncope 3. Narrow Pulse Pressure - decreased sys BP & normal dias 4. Sustained apical impulse - not late in dz (dilatation) 5. S4 = severe LVH in yount pts 6. Late peaking systolic murmur - radiates into carotid - intensity coorrelates w/ severity - Ejection sound (esp in young) Murmur Increases w/ decreased AF (amyl nitrate) Decreased w/ decreased preload (Valsalva) - Squatting = louder (^ preload/AF) |
|
chronic AR
- causes *ALSO BOOT SHAPED* - can look like chronic MR |
Essential HTN & Bicuspid Aortic Valve
1st: ^ AF 2.^ Preload (LVEDV) is initial compensatory mechanism 3. Dilatation 4, eccentric hypertrophy (more efficient) 5. Sys dysfunction & CHF 6. ^ sns -----> ^ sys vasc r = ^ AF (rpt) Decreased Diastolic BP + HUGE SV = Wide pulse pressure |
|
CHRONIC AR
- Paradoxical effect of isotonic/aerobic exercise |
Exercise --> tachy & vasodilation
- Less time for regurg to happen - Less AF = ^ CO - Symptoms can improve w/ exercise |
|
SYMPTOMS/SIGNS OF AR
DOC = ARTERIOVASODILATORS (DECREASE AF) |
1. Palpitations
- HUGE SV 2. ^ pawp = DOE, orthopnea, PND 3. Angina - less blood going to coronary aa - esp in those w/ CAD 4. Peripheral manifestations 2' big SV - Corrigan's/waterhammers, quincke's, Duroziez's (sys-dias bruit in femoral), Hill's sign(?) 5. Hyperdynamic apical impulse - displaced down & left 6. S4 7. Left lung can be compressed by massive LV ~ewart's sign: dull, ^VTF, Egophony @ tip of scapula 8. 2 DIASTOLIC MURMURS - blowing, high pitched - low, rumbing (austin flint): fxnal mitral stenosis = BAAAD! |
|
ACUTE AR
- causes - pathophys |
#1. Infectious endocarditis (USA)
---> VALVE CUSP PERF LVEDV only increases a little (compared to Chronic AR), but LVEDP ^^^^^^ ---> pulmonary edema & way decreased CO Pulse pressure may be normal (Normal Sys BP & Dias BP = LVEDP) same curves as normal, just increased preload (normal AF & contractility) |
|
MYOCARDIAL OXYGEN CONSUMPTION (MVO2)
- determinants - highest/lowest times |
65% used for Contraction; 15% = relaxation
TOP 3: HR, Afterload, & Contractility - Proportional increases Minor: Diastolic Filling (Preload) Highest during isovolemic contraction - MVO2 is greater in pressure overloaded states (increased isovolemic contraction time) Lowest = late diastolic filling **CBF is opposite** |
|
DOUBLE PRODUCT
- use - exceptions/limitations |
Used in absence of LV outflow obstruction to predict MVO2
- underestimates MVO2 if obstruction is present (AS) (Sys BP does NOT = AF) *O2 consumption = HR x sys BP* (Ignores the contribution of contractility & preload, but that's ok) |
|
Coronary Circulation
- MVO2 at rest (extraction) how CBF adjusts to meet increased myocardial O2 demand |
Myocardial O2 extraction is almost maximal at rest (>90%)
- more capillaries/mm2 = ^ O2 extraction *AV O2 difference is the largest for any organ in the body - extraction is already maximal - CO needs to increase for higher O2 demand *O2 consumption is FLOW-LIMITED* - that's why heart is so susceptible to ischemia |
|
CORONARY BLOOD FLOW
- MAJOR DETERMINANTS |
A. Perfusion Pressure
- Aortic Pressure - Proportion of time <3 spends in diastole (tachy vs. brady) - RA-P (drains into RA) B. Coronary Vascular Resistance - Extracoronary resistance - LV diastolic P - ANS - Autoregulation:myogenic & chemical - Vasc Endothelium (NO) |
|
PERFUSION PRESSURE
- determinants |
1. Aortic Pressure
- Coronary ostia are partly occluded by aortic valve cusps during systole = Sys coronary a. P < Sys BP (diastolic pressures are the same) 2. Proportion of time spent in Diastole - Perfusion pressure drops during tachycardia 3. Right Atrial Pressure Q = (Aortic diastolic P - RA P) / Coronary Resistance - Increases in RA-P = reduced CBF (coronary aa drain into RA) *Severe tricuspid stenosis* |
|
CORONARY VASCULAR RESISTANCE
1. Extracoronary resistance 2. LV diastolic pressure |
1. Extracoronary Resistance
- systole compresses intramural vessels --> CBF to LV drops almost completely during systole *This is only a factor in RVH for Right heart* 2. LV Diastolic Pressure - High LV-EDP compresses subendocardium --> risk of ischemia - Endocardium is farthest away from large epicardial coronary aa. |
|
CORONARY VASCULAR RESISTANCE
3. ANS 4. AUTOREG***** - most important det. of Coronary resistance 5. VASC ENDOTHELIUM |
3. ANS
A. Tonic SNS: a1-R = vasoconstrict; B1 = Tachy - overwhelmed by autoreg in exercise B. Vagal: little direct effect - indirect vasoconstriction (decreases metab) - M2-mediated brady - M3: vasodilate 4. AUTOREGULATION: - CBF matched 2 <3s metabolic activity A. Myogenic: most important in EPICARDIAL prearterioles B. Chemical: most imp. in Intramural aa. - Adenosine: best chem. mediator = Myocardial ischemia/hypoxemia MECH: A2-R on endothelium opens Katp channels & closes Ca2+ channels = hyperpolarize & RELAX coronary smooth mm = VASODILATE! INCREASE CBF --> Perfusion pressure rises 2' vasodilation ---> Adenosine is washed out ---> Coronary resistance increases (constant CBF) *in NON-autoregulating vasc bed, CBF is proprotional to increase in perfusion pressure |
|
VASCULAR ENDOTHELIUM & CORONARY A. RESISTANCE
|
RELEASES CHEMICAL MEDIATORS
1. NO <--- L-arg --> Vasc. Smooth mm ---> increases cGMP & opens K+ channels (hyperpolarize = relax!) *similar to Nitroglycerin (makes NO) 2. NO also has anti-atherogenic properties (inhib lipid peroxidation platelet aggreg/activation, monocyte adhesion, vasc smooth mm. prolif) 3. Endothelin-1: vasoconstrictor - opp of NO - released in response to shear stress & ATN II & catecholamines --> ET-A receptors --> PLC, IP3, Ca2+ = CONSTRICT! **HTN, Hypercholesterolemia, smoking, & DM = Decrease NO & Increase Endothelin-1 |
|
MYOCARDIAL ISCHEMIA VS. HYPOXIA
|
ISCHEMIA
Decreased coronary perfusion ---> Myocardial O2 deprivation & inadequate removal of cellular metabolites - Develops whenever O2 demand > supply = chronic stable angina (does NOT explain acute coronary syndromes, esp stunning & reperfusion) HYPOXIA: Adequate perfusion, but reduced O2 supply |
|
MYOCARDIAL STUNNING
- what - mech - tx |
Acute, brief, sever ischemia --->
Reversible contractile dysfunction *Duration of stunning proportional to duration of ischemia MECH: Transient accum of Ca2+ = proteolysis of troponin I & uncouples cardiac excitation from contraction tx: - Beta agonists - milrinone - digitalis glycosides *If its the cause of sys dysfxn after acute ischemia --> be aggressive!* - CABG or angioplasty |
|
REPERFUSION INJURY
- what - mech - results *can increase final infarct size by as much as 50%!* |
1. Acute ischemia
2. Coronary reperfusion w/ t-PA, angioplasty, stenting, or CABG 3. ischemic myocardiocytes = irreversible necrosis MECH: 1. bring in O2 radicals & neutrophils 2. destroys cell membranes (lipid peroxidation) 3. Massive Ca2+ overload - opens mitochondrial permeability transition pore (PTP) - uncoupled oxidative phos = ATP depletion; cell dies *Also proteolysis* 4. Irreversible systolic dysfxn *UNLIKE stunning, beta agnoists or digitalis is NOT going to help |
|
oxygen derived free radicals in ischemic myocardium
- how do they get there? - why are they increased in ischemic injury? |
By-product of purine metabolism
*Normal: xanthine is end product of purine - Xanthine dehydrogenase reduces NAD+ to make uric acid - no free radicals made ISCHEMIC INJURY: xanthine dehydrogenase --> xanthine oxidase (2' Ca2+ accum) - also converts it to uric acid, but makes tons of superoxide radicals *Reperfusion brings in lots of O2 so the large amts of converted xanthine oxdiase can make free radicals* |
|
ISCHEMIC MYOCARDIAL METABOLISM
- mech of switching - WHY? - when CBF stops altogether |
1. PPAR-a
- activation upreg's genes involved in mitochondrial fatty acid oxidation - DOWN-reg'd in severe ischemia 2. PPAR-y - UPreg'd during severe ischemia - Upreg's genes for glucose metabolism - also upregulated in fetal heart, concentric hypertrophy (pressure overload), etc. - Glucose metab is more efficient than FFAs (6.3 vs 4.6 ATP / O2) *NO CBF: 1. glucose runs out w/in minutes 2. Anaerobic glycosis 3. Glycogen stores depleted in 20-30 min. = NO MORE ATP! |
|
ISCHEMIC MYOCARDIAL METABOLISM
effects of: - lactic acid - ATP depletion tx: - lysosomes - free radicals **DIASTOLIC DYSFXN IS 1ST FUNCTIONAL MANIFESTATION OF ISCHEMIA***!!!! |
ischemia --> anaerobic glycosis
1. LACTIC ACID: end product - intracellular acidosis inhibits regulatory proteins - stops glycogen/glucose breakdown - Inhibits acyl-CoA transfer from cyto to mito (no beta-ox) 2. ATP DEPLETION: Na/K ATPase stops - ATP-dep K+ channels open - Na+ builds up inside (increased NHE & no NK pump) - Ca2+ builds up inside (reverse-mode Na+/Ca2+ xchange) --> necrosis / apoptosis --> diastolic dysfxn tx: (Ca2+ overload = reduced ATP production) - Beta blockers - Ca2+ channel blockers: protect mitos from calcium overload *BOTH Reduce amt of necrosis following ischemic injury* |
|
ISCHEMIC MYOCARDIAL METABOLISM
- lysosomes - free radicals |
LYSOSOMES:
- spit out acid hydrolases activated by intracellular acidosis - intracellular digestion O2-DERIVED FREE RADICALS: - Accum & damage cell organelles & membranes - ischemia > 20 min = membrane peroxidation = necrosis = elevated CPK-MB & troponins in circulation |
|
FUNCTIONAL CONSEQUENCES OF ISCHEMIA
|
ACUTE CORONARY A. OCCLUSION -->
1. Regional systolic dysfxn - high intracell H+ vs. Ca2+ for troponin binding sites - Subendocardial surface = highest risk (farthest away from epicardial aa) 2. Systolic dysfxn - Decreased SV, EF, CO - higher LV- EDP & EDV 3. LV FAIL - CO decreases even more = decreased coronary perfusion & worse ischemia *Electrical conduction system is vulnerable --> ventricular dyssynchrony --> worse systolic fxn ISCHEMIA = IMPAIRED RELAXATION - diastolic dysfxn (much worse when + LVH) MECH: Impaired serca - Ca2+ channel blockers kinda work --> pulmonary congestion worsens |
|
WHICH ARTERIES SUPPLY WHICH AREAS OF THE HEART
|
LAD: Anterior LV & RV
- also anterolateral RV - septum (along w/ RCA) LCX: Lateral LV RCA: Posterior LV & RV |
|
ECG LEADS
- area of myocardium - coronary a. |
A. 2,3, aVF: Inferior; RCA
B. V1-V2 (R waves): Posterior, RCA C. V1-V2 (Qwaves): Septal, RCA or LAD D. V1-V3: Anteroseptal; LAD E. V3-V4: Apical; LAD F. I, aVL: Basolateral, marginal br of LCX or diagonal br of LCA G. V5-V6: Apicolateral, LAD or Post. desc br of RCA, or marginal br of LCX |
|
ETIOLOGIES OF MYOCARDIAL ISCHEMIA
- ATHEROSCLEROSIS (lipid oxidation theory of atherosclerosis) (TNFa & IL-1 = inflam cytokines) - NF-kB = p50 & p65 *Predilection for proximal segments of coronary aa & branch points (turbulence) *Also HTN/DM/SMOKING - infxn - Homocysteine |
Most important cuase of ischemic HD
- Chronic infalmm process *Endothelial cell Dysfxn = cardinal features - known risk factors injure endothelium Lipid Ox. Theory 1. Fatty Streak a. Endothelium binds oxidized-LDL (PUFAs got peroxidized by free radicals) - apoB in LDL has neg charge = sticky b. Internalized LDL activates NF-kB cascade (inflamm & ICAMs) c. CAMs attract monocytes & T cells d. Oxidized-LDL accum & explodes endothelial cell: contents in subintimal space e. Monocyte-derived macros eat oxidized LDL = foam cells 2. Fibrous-capped plaques - prone to thrombosis, hemorrhage & ulceration a. Oxizided LDL inhibits NO & increases Endothelin-1 = proliferation of vasc smooth mm & collagen in subintimal space b. Fibrous cap = vasc smooth mm & collagen - Th1 CD4 degrades the cap (unstable angina & MI - Th2 CD4 stabilizes/thickens cap (chronic stable angina) *W/ Athero, Coronary vasodilation does NOT occur during exercise bc they are maximally dilated at rest & NO can't be released* |
|
ETIOLOGIES OF MYOCARDIAL ISCHEMIA
(Atherosclerosis) - HTN/DM/SMOKING (- INFXN) (- HOMOCYSTEINE) (-CRP) |
1.HTN: decreases NO, ^ PGs & Endothelin 1
- Increases Physical stress on plaques = increased rate of complicated plaque formation 2. DM: - increases LDL cholesterol - lipoproteins are glycosylated = injured endothelium --> less NO & ^ platelet reactivity 3. Smoking/Nicotine: - Lowers HDL cholesterol - increases platelet reactivity & fibrinogen levels - injures endothelial cells |
|
ETIOLOGIES OF MYOCARDIAL ISCHEMIA
- INFXN - HOMOCYSTEINE (atherosclerosis & htn/dm/smoking & CRP) |
INFXN
- possible chronic infxn can exacerbate coronary atherosclerosis - Chlamydia pneumoniae (intracell parasite) - contribues to plaque rupture HOMOCYSTEINE - AA made from methionine metabolism - SAM = activated methionine - FATES: re-methylated = folate & vit. B12 or condensed to make cysteine (if either pathway is limited, plasma homocysteine increases) *homocysteinE IS bad - TOXIC to endothelium - Mitogenic for vasc smooth mm - ^ Platelet aggreg - Impairs fibrinolysis (inhibits t-PA & protein C) *Hereditary elevations of plasma homocysteine = linked w/ CAD* |
|
ETIOLOGIES OF MYOCARDIAL ISCHEMIA
CRP - what - from where? - FXN -tx (+ atherosclrosis, HTN/DM/SMOKING, Homocysteine, Infxn) |
C reactive Protein = Acute phase reactant
- inflamm; increased in atherosclerosis - strong predictor for presence of CAD - worsens athero HOW IT'S MADE: 1. Activated t cells & macros in plaque = IL-6 by plaque & adipose 2. IL-6 tells liver to make CRP WHAT IT DO 1. DOWNreg's NO synthase & increases NO degradation 2. UPREGs endothelin-1 3. UPregs NF-kB 4. UPregs MMPs - destabilizes fibrous cap 5. UPregs ATN-II receptors on vasc smooth m. LOWER CRP: - STOP SMOKING - WORK OUT - BP CONTROL - LOWER CHOLESTEROL (HMG-CoA inhibis) |
|
CORONARY THROMBOSIS
- how does it develop? - ECG manifestations *Abciximab: anti-GP2B/3A-R Ab* *Agonists: Adenosine, thrombin, TXA2, collagen, Epi, etc* (anything making platelets sticky) |
Dynamic interaction bw damaged vasc endothlium - platelet aggregs - coronary vasoconstriction
1. Trigger: Ruptured plaque (thin cap -Th1, necrotic core) 2. Exposed subendothelial collagen --> Platelet aggreg (Upreg's GP2b/3a receptors) 3. Activated platelet receptors bind FIBRINOGEN 4. Platelet link to form a thrombus *Vasoconstriction triggered by TX-A2 (platelets) & bleeding into vessel wall ECG: - ST-elevation MI (STEMI): complete occlusion = transmural infarction vs. - Partial occlusion = NSTEMI (necrosis) or unstable angina (UA - subendocardial ischemia) |
|
CAUSES OF MYOCARDIAL ISCHEMIA
COMMON VS RARE |
#1. Atherosclerosis
#2. Coronary Thrombosis rare: 3. coronary emboli 4. Global HypoTN 5. Increased O2 demand (AS) |
|
CORONARY ARTERY SPASM/vasoconstriction
mechanism vasospasm = ischemia & rarely MI |
1. Endothelial dysfxn
- more ET-1 & less NO 2. Parasympathetic hypoactivity / vagal withdrawal - w/ or w/o increase in alpha-adrenergic tone 3. Overactive GTP rho-kinase in VSM - phosphorylates myosin lt chain - inhibits myosin phosphatase - increases sensitivity of vsm TO CA2+ **Coronary vasoconstriction = mechanism of injury in cocaine & amphetamine users |
|
GLOBAL HYPOTN & MI
|
- States of hemodynamic shock
- may precipitate myocardial ischemia even in absence of critical coronary a. atenosis Hemodynamic shock: - increases myocardial O2 demand - decreases coronary a. perfusion pressure (esp. in subendocardium) *can progress to global subednocardial MI* |
|
INCREASED O2 DEMAND & MI
|
^ O2 demand in presence of moderate coronary a stenosis can ---> severe ischemia
*already maximally dilated at rest* CAD + STATESOF HIGH DEMAND (old pts): 1. Anemia 2. infxn 3. hyperthyroidism 4. LVH (as) when coronary arteris are normal: (young pts) 1. severe AS & LVH 2. Tachyarrhythmia+ systemic hypoTN 3. HCM - intramural coronary aa are abrnomally small |
|
CLINICAL MANIFESTATIONS OF CAD (Cardiac Ischemia)
|
1. Chronic stable angina
2. Unstable angine 3. Variant/Prinzmetal's angina 4. MI 5. Sudden Death 6. Asymptomatic |
|
CHRONIC STABLE ANGINA
- TYPE OF PLAQUE - WHEN? - DESCRIBE - ECG |
Uncomplicated plaque
- thick, fibrous cap - fixed obstruction - not prone to rupture Any situation that increases O2 demand > supply (tachy, pregnancy, fever, HTN, HCM, Anemia, etc, increased AF/ cold shower) CONSISTENT pattern, frequency & intensity of pain (does NOT progress/worsen with time); relieved w/ same dose of nitroglycerin each time 1. Retrosternal chest pain/pressure of SHORT duration 2. Precipitated by certain things 3. Radiates to ulnar aspect of L arm, lower jaw, neck/shoulders 4. Relieved w/ rest & nitroglycerin also: nauea, dyspnea, diaphoresis, feelings of anxiety ECG during an attack - ST segment depression - T wave inversion *normal ECG during attack* |
|
CHRONIC STABLE ANGINA
- PAIN MEDIATOR - SILENT ISCHEMIA |
Pain mediator = ADENOSINE
- low CBF prevents removal, stimulates A1-R of perivascular aff SNS Silent ischemia: ischemia w/ chest discomfort - people w/ messed up pain receptors/mechanism = Elderly, previous MI, DM, CABG |
|
VARIANT ANGINA
(PRINZMETAL'S ANGINA) - mech - population type - ecg - describe |
Coronary a. spasm
- often suprimposed on single vessel stenosis **in younger pts - normal coronary a. spasms (no stenosis)** 1. Chest pain - usually at rest or nighttime - wakes u up! - similar symptoms as stable angina - LESS THAN 20 min. ECG: - ST segment elevation (less often depression) = transmural ischemia (leakage of K+ lowers baseline; "looks like elevation") |
|
unstable angina
- mech - describe - course - tx |
Multiple, complicatd plaques
- thin fibrous cap - prone to rupture Partially occluding thrombus + vasoconstriction (after rupture) = Unstable Angina - CBF restored in <20 min (>20 min = MI) INCREASE in freq, duration or severity of pain - not attributale to obvious increase in O2 demand - NEW ONSET chest pain (during past 4-6 wks) in prev. asymptomatic TX: LIKE AN MI - At SUPER high risk for MI and should be hospitalized |
|
UNSTABLE ANGINA VS. MI
- DURATION - EXTENT OF OCCLUSIONS |
DURATION:
MI: >20 MIN U. Angina: <20 min EXTENT OF OCCLUSION - Transmural: ST elevation - Subendocardial: ST depression |
|
MYOCARDIAL INFARCTION
= DESCRIBE = TYPES = ECG - DX |
1. STEMI: ST seg elevation
- COMPLETE coronary a. occlusion + complicated plaque = majority of MIs; higher mortality 2. Non-STEMIs: plaque rupture + incomplete coronary a. occlusion SEVERE chest pain > 20 min. - precordial/retrosternal pain - radiation - NOT releived w/ NG or cessation of activity - Pain usually FOLLOWS exertion/excitement (angina = pain DURING exertion) 1/4 of MIs = no chest discomfort - any NEW ONSET heart failure, arrhythmias, hypoTN, normalization of BP in HTN pts, or confusion in elderly = ECG!!! (silent infarcts) |
|
MI
- PHYSICAL EXAM = ECG - DX |
NORMAL PE: small infarcts
- ANS hyperactivity = common - LV FAIL: pulmonary congestive signs & S3 ECG: - STEMI: ST elevation + Q waves in affected arteriolar distribution (don't always have Q waves) dx: - serial ECGs - Serum markers: CPK-MB, Troponin-T, Troponin-I (elevated post-MI; normal in chronic/stable angina) *serum levels take several hours to rise |
|
COMPLICATIONS OF MI
|
#1. ARRHYTHMIAS
- most common cause of death post-MI #2. CARDIOGENIC SHOCK - 2nd most common cause of death post-MI 3. Ventricular septal rupture 4. Papillary Muscle Rupture 5. Ventricular Free wall rupture 6. LV thrombus |
|
ARRHYTHMIAS & MI
|
MOST COMMON CAUSE OF DEATH POST-MI
1. V-fib: most deaths during first 24 hrs - reduced CO 2. A-fib/flutter: further myocardial damage - increased O2 demand 3. 2nd-3rd degree AV block - decrease HR - 3rd Degree block = most likely after anterior MI *Sinus brady is HELPFUL as long as HR is adequate to maintain CO - decreases O2 demand & protects heart from further ischemia |
|
CARDIOGENIC SHOCK & MI
lv vs rv - tx |
2ND most common cause of death post-MI
- develops when >40% of ventricular mm. is damaged LV shock <-- systolic pump failure - Low CO - Systemic hypoTN - Elevated systemic vasc R - Elevated LV-EDV & LV-EDP - Elevated PAWP (>15 mmHg) & congestion RV SHOCK: limited LV filling - low CO - same as above - LOW PAWP (<6 mmHg) - HIGH JVP TX: For LV SHOCK: Diuretics & venous vasodilators - lower LVEDP, improve pulmonary congestion / PCWP **BUT NOT FOR RV SHOCK** - makes it worse (reduced RVEDV) ---> SUPER LOW CO |
|
VENTRICULAR SEPTAL RUPTURE & MI
|
5% of MI-related deaths
- 3-4 dyas or 10-12 days post-MI - Septal rupture is more common in anterior MI (vs inferior MI) = Cardiogenic shock + new holosytolic murmur - pulmonary edema --> dyspnea - Increased oxygenation in Right heart |
|
PAPILLARY MUSCLE RUPTURE & MI
|
2-7 days post-INFERIOR MI
= Acute pulmonary edema & low CO - early systolic murmur - Decrescendos towards S2 - milder forms of papillary dysfxn = new holosystolic murmur *Post papillary mm is most often afftected* - only fed by 1 artery (post. desc br of RCA) |
|
VENTRICULAR FREE-WALL RUPTURE & MI
|
15-20% of in-hospital MI-related deaths
(3rd most common cause of death post-MI) 3-5 days post-MI female, old, HTN, recent NSAID use - occluded LCA predisposes pts (Anterior or lateral STEMI) SYMPTOMS: - repetitive vomiting - pleuritic chest pain - restless; agitated - SYSTEMIC HYPOTN - ELEVATED JVP (cardiac tamponade) --> Equalization of diastolic pressures across all FOUR <3 chambers) = ELECTROMECHANICAL DISSOCIATION - electrical activity persists in absence of BP, PULSE, OR audible heart sounds |
|
LV THROMBUS FORMATION & MI
|
Anterior MI & apical MI of LV
--> predisposis to LV thrombus --> systemic emboli first few days post-MI - pedunculated & movile thrombi are more likely to embolize *UNCOMMON after inferior MI* |